Trial Profile
Safety and Immunogenicity of Adjuvanted Versus High-Dose Inactivated Influenza Vaccines in Older Adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 24 May 2019 Status changed from recruiting to completed.
- 25 Sep 2017 Status changed from not yet recruiting to recruiting.
- 14 Jun 2017 New trial record